OTCMKTS:CHEOF

Cochlear Stock Forecast, Price & News

$151.50

+0.81 (+0.54 %)

(As of 01/25/2021 05:19 PM ET)

Add

Compare

Today's Range

$151.50

Now: $151.50▼

$151.50

50-Day Range

$137.75

MA: $155.54▼

$160.00

52-Week Range

$95.00

Now: $151.50▼

$162.50

Volume102 shs

Average Volume225 shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7, Nucleus 6, Nucleus CP802, and Kanso sound processors; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha soundarc, Baha 5 sound processor, and Baha sound processor. It also provides Cochlear true wireless accessories comprising mini microphones, phone clips, and TV streamers; Nucleus water-safe accessories; and training and development services. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

Overall MarketRank^™

0.50 out of 5 stars

Medical Sector

1506th out of 1,922 stocks

Medical Devices Industry

9th out of 18 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Cochlear.

2.5 Community Rank

Outperform Votes
Cochlear has received 3 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Cochlear has received 3 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Cochlear has received 50.00% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Cochlear and other stocks. Vote “Outperform” if you believe CHEOF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CHEOF will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Cochlear does not currently pay a dividend.
Dividend Growth
Cochlear does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cochlear insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Medical Devices

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:CHEOF

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.cochlear.com

Phone61 2 9428 6555

Employees4,000

Year FoundedN/A

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A

Market CapN/A

Next Earnings DateN/A

OptionableNot Optionable

$151.50

+0.81 (+0.54 %)

(As of 01/25/2021 05:19 PM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive CHEOF News and Ratings via Email

Sign-up to receive the latest news and ratings for CHEOF and its competitors with MarketBeat's FREE daily newsletter.

Cochlear (OTCMKTS:CHEOF) Frequently Asked Questions

How has Cochlear's stock price been impacted by COVID-19?

Cochlear's stock was trading at $129.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CHEOF stock has increased by 17.4% and is now trading at $151.50.
View which stocks have been most impacted by COVID-19.

Is Cochlear a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cochlear in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Cochlear stock.
View analyst ratings for Cochlear or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Cochlear?

Wall Street analysts have given Cochlear a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cochlear wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Cochlear?

Cochlear saw a drop in short interest in the month of December. As of December 31st, there was short interest totaling 10,800 shares, a drop of 75.7% from the December 15th total of 44,500 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is currently 108.0 days.
View Cochlear's Short Interest.

Who are some of Cochlear's key competitors?

Some companies that are related to Cochlear include Adherium Limited (ADR.AX) (ADR), ADM Tronics Unlimited (ADMT), Allegra Orthopaedics Limited (AMT.AX) (AMT), Analytica Limited (ALT.AX) (ALT), AnteoTech Limited (ADO.AX) (ADO), Atomo Diagnostics Limited (AT1.AX) (AT1), AVITA Medical, Inc. (AVH.AX) (AVH), Azure Healthcare Limited (AZV.AX) (AZV), Cannabix Technologies (BLO), Cochlear (CHEOY), Cochlear Limited (COH.AX) (COH), Cyclopharm Limited (CYC.AX) (CYC), EMvision Medical Devices Limited (EMV.AX) (EMV), Fisher & Paykel Healthcare Co. Limited (FPH.AX) (FPH) and GI Dynamics, Inc. (GID.AX) (GID).
View all of CHEOF's competitors.

Who are Cochlear's key executives?

Cochlear's management team includes the following people:

Mr. Diggory William Howitt BE (Hons), MBA, CEO, MD, Pres & Exec. Director (Age 53)
Mr. Brent Andrew Cubis B.Com., C.A., BComm, CA, Chief Financial Officer
Mr. Jan Janssen, Chief Technology Officer
Mr. Richard Brook, Pres of EMEA & Latin American Region
Mr. Anthony Manna, Pres of Americas Region
Mr. Anthony Bishop, Pres of Asia Pacific Region
Mr. David Hackshall, Chief Information Officer
Ms. Kristina Devon, Head of Investor Relations
Ms. Jennifer Stevenson, Head of Corp. Communications
Mr. Dean Phizacklea, Sr. VP of Global Marketing

What is Cochlear's stock symbol?

Cochlear trades on the OTCMKTS under the ticker symbol "CHEOF."

How do I buy shares of Cochlear?

Shares of CHEOF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cochlear's stock price today?

One share of CHEOF stock can currently be purchased for approximately $151.50.

What is Cochlear's official website?

The official website for Cochlear is www.cochlear.com.

How can I contact Cochlear?

The company can be reached via phone at 61 2 9428 6555.

This page was last updated on 1/26/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here